Transcription of COVID-19 mRNA Vaccine SPIKEVAX™ Supplier: Moderna
{{id}} {{{paragraph}}}
Example: dental hygienist
COVID-19 mRNA Vaccine SPIKEVAX™ Supplier: Moderna
Communicable Disease Control Manual April 13, 2022 Chapter 2: Immunization Part 4 - Biological Products 1 COVID-19 mRNA Vaccine SPIKEVAX Supplier: Moderna INDICATIONS: Individuals 6 years of age and older. See COVID-19 Vaccine Eligibility The Vaccine is not approved for use in those less than 6 years of age. DOSES AND SCHEDULE: Primary series for individuals 6-11 years of age A: 2 doses given as mL IM, 8 weeks apart. B, C Primary series for individuals 12 years of age and older A: 2 doses given as mL IM, 8 weeks , C, D For individuals who are moderately to severely immunosuppressed (see COVID-19 Vaccine Eligibility), a 3-dose primary series is recommended. E The 3rd dose should be provided at least 28 days after the 2nd dose. For those 12 years of age and older, Moderna COVID-19 Vaccine is preferentially recommended for all doses in the primary series.
• Following withdrawal of all available 0.5 mL doses, the residual vaccine from up to three ... post-vaccination of at least 30 minutes. • Wait until symptoms of an acute illness are resolved before vaccinating with COVID-19 vaccine to differentiate symptoms of …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: